Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
Status:
Unknown status
Trial end date:
2020-05-20
Target enrollment:
Participant gender:
Summary
Our study is a prospective double-blind randomized study performed in the Emergency
Department (ED). The objective of our study was to demonstrate the additive effect of high
and repeated doses of inhaled budesonide combined with the standard treatment of acute asthma
in adult managed in the ED